Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (471-480 of 514) with videos related to

Pageof 52
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2010
Severe novel influenza A (H1N1) infection in cancer patientsL A Hajjar, T Mauad, F R B G Galas, et al.
JAMA Oncology|October 14, 2016
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical TrialMichael P Chu, J Randolph Hecht, Dennis Slamon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 30, 2015
Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropeniaM P Freire, D de Oliveira Garcia, C P Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Potential regional differences for the tolerability profiles of fluoropyrimidinesDaniel G Haller, Jim Cassidy, Stephen J Clarke, et al.
JCO Global Oncology|July 11, 2024
Unplanned Hospital Admissions in Patients With Solid Tumors in Brazil: Causes and Progressive Disease's Impact on OutcomesCassio Murilo Hidalgo Filho, Felippe Lazar Neto, Vitor Pinheiro Sobottka, et al.
The Lancet. Oncology|November 22, 2012
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, et al.
Nature|April 3, 2020
Mirror-symmetry violation in bound nuclear ground statesD E M Hoff, A M Rogers, S M Wang, et al.
JCO Global Oncology|July 6, 2021
Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locusR Freedman, H Coon, M Myles-Worsley, et al.
Pageof 52

Showing results (471-480 of 514) with videos related to

Sort By:
Pageof 52
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2010
Severe novel influenza A (H1N1) infection in cancer patientsL A Hajjar, T Mauad, F R B G Galas, et al.
JAMA Oncology|October 14, 2016
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical TrialMichael P Chu, J Randolph Hecht, Dennis Slamon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 30, 2015
Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropeniaM P Freire, D de Oliveira Garcia, C P Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Potential regional differences for the tolerability profiles of fluoropyrimidinesDaniel G Haller, Jim Cassidy, Stephen J Clarke, et al.
JCO Global Oncology|July 11, 2024
Unplanned Hospital Admissions in Patients With Solid Tumors in Brazil: Causes and Progressive Disease's Impact on OutcomesCassio Murilo Hidalgo Filho, Felippe Lazar Neto, Vitor Pinheiro Sobottka, et al.
The Lancet. Oncology|November 22, 2012
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, et al.
Nature|April 3, 2020
Mirror-symmetry violation in bound nuclear ground statesD E M Hoff, A M Rogers, S M Wang, et al.
JCO Global Oncology|July 6, 2021
Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locusR Freedman, H Coon, M Myles-Worsley, et al.
Pageof 52